Product Description

Jubi-R Injection consists of the active ingredient Remdesivir. It is an approved drug in adult and pediatric patients (12 years of age and older, at least weighing 40 kg) for the treatment of coronavirus disease 2019 (COVID-19) requiring hospitalization. It will only be given to patients who have pneumonia, and need extra oxygen to help them breathe, but who are not on artificial ventilation. This injection should be administered only in a hospital or healthcare setting capable of providing acute care. Inform your physician if you are taking theophylline, midazolam, chloroquine, hydroxychloroquine or pitavastatin as Remdesivir may affect the way these medicines work. Common side effects include nausea and liver disorders.

How to use

This injection is intended for administration through an intravenous route after reconstitution and dilution. Administer only under the supervision and monitoring of a qualified healthcare professional. 

Uses

Treatment of Coronavirus disease (COVID-19)

Side Effects

Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.

Serious:

• Hypersensitivity including infusion-related and Anaphylactic reactions.
• Changes in heart rate or BP
• Fever
• Shortness of breath, wheezing
• Swelling of lips, face, or throat
• Shivering
• Sweating
• Rash

Common

• Nausea
• Liver disorders

Storage

Store below 30℃